Sintilimab/fruquintinib combo meets primary PFS end point in advanced RCC - Urology Times
20 hours ago • Google News
Provident Financial Services Inc (PFS)
US$ 19.190.21%
Price Chart
Key Statistics
Market Cap
$ 2.23B
P/E Ratio
16.29
Revenue (TTM)
$ 607.16M
Volume
763.24K
52W High
$ 21.96
52W Low
$ 12.52
Dividend Yield
5.64%
Beta
1.04
Technicals
50-Day MA
18.3046
200-Day MA
18.1123
52 Week High
21.958
52 Week Low
12.5242
About PFS
Provident Financial Services, Inc. operates as the bank holding company for Provident Bank that provides various banking products and services to individuals, families, and businesses in the United St.
Employees
1753
Headquarters
Jersey City, NJ
CEO
Mr. Anthony J. Labozzetta
Latest News
Fruquintinib/Sintilimab Generates Favorable PFS Outcomes in Advanced RCC - OncLive
23 hours ago • Google News
ITM-11 Yields Higher PFS Over Everolimus in SSTR+ GEP-NETs - www.oncnursingnews.com/
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg